344 related articles for article (PubMed ID: 19643088)
1. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma.
De Stefano I; Raspaglio G; Zannoni GF; Travaglia D; Prisco MG; Mosca M; Ferlini C; Scambia G; Gallo D
Biochem Pharmacol; 2009 Dec; 78(11):1374-81. PubMed ID: 19643088
[TBL] [Abstract][Full Text] [Related]
2. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
3. Skin tumor promotion by argemone oil/alkaloid in mice: evidence for enhanced cell proliferation, ornithine decarboxylase, cyclooxygenase-2 and activation of MAPK/NF-kappaB pathway.
Ansari KM; Das M
Food Chem Toxicol; 2010 Jan; 48(1):132-8. PubMed ID: 19796664
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer.
Pica F; Balestrieri E; Serafino A; Sorrentino R; Gaziano R; Moroni G; Moroni N; Palmieri G; Mattei M; Garaci E; Sinibaldi-Vallebona P
Anticancer Drugs; 2012 Jan; 23(1):32-42. PubMed ID: 21849887
[TBL] [Abstract][Full Text] [Related]
5. Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition.
Kalogris C; Garulli C; Pietrella L; Gambini V; Pucciarelli S; Lucci C; Tilio M; Zabaleta ME; Bartolacci C; Andreani C; Giangrossi M; Iezzi M; Belletti B; Marchini C; Amici A
Biochem Pharmacol; 2014 Aug; 90(3):226-34. PubMed ID: 24875448
[TBL] [Abstract][Full Text] [Related]
6. Characterization and assessment of nanoencapsulated sanguinarine chloride as a potential treatment for melanoma.
Rosen J; Landriscina A; Adler BL; Krauz A; Doerner J; Navati M; Musaev T; Gravekamp C; Nosanchuk J; Friedman AJ
J Drugs Dermatol; 2015 May; 14(5):453-8. PubMed ID: 25942662
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of sanguinarine on ultraviolet B-mediated damages in SKH-1 hairless mouse skin: implications for prevention of skin cancer.
Ahsan H; Reagan-Shaw S; Eggert DM; Tan TC; Afaq F; Mukhtar H; Ahmad N
Photochem Photobiol; 2007; 83(4):986-93. PubMed ID: 17645675
[TBL] [Abstract][Full Text] [Related]
8. Sanguinarine cytotoxicity on mouse melanoma K1735-M2 cells--nuclear vs. mitochondrial effects.
Serafim TL; Matos JA; Sardão VA; Pereira GC; Branco AF; Pereira SL; Parke D; Perkins EL; Moreno AJ; Holy J; Oliveira PJ
Biochem Pharmacol; 2008 Dec; 76(11):1459-75. PubMed ID: 18692024
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of sanguinarine, chelerythrine and chelidonine on DNA damage and cell viability in primary mouse spleen cells and mouse leukemic cells.
Kaminskyy V; Lin KW; Filyak Y; Stoika R
Cell Biol Int; 2008 Feb; 32(2):271-7. PubMed ID: 18029203
[TBL] [Abstract][Full Text] [Related]
10. Sanguinarine causes DNA damage and p53-independent cell death in human colon cancer cell lines.
Matkar SS; Wrischnik LA; Hellmann-Blumberg U
Chem Biol Interact; 2008 Mar; 172(1):63-71. PubMed ID: 18243168
[TBL] [Abstract][Full Text] [Related]
11. Apoptotic response of uveal melanoma cells upon treatment with chelidonine, sanguinarine and chelerythrine.
Kemény-Beke A; Aradi J; Damjanovich J; Beck Z; Facskó A; Berta A; Bodnár A
Cancer Lett; 2006 Jun; 237(1):67-75. PubMed ID: 16019128
[TBL] [Abstract][Full Text] [Related]
12. Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion.
Jang BC; Park JG; Song DK; Baek WK; Yoo SK; Jung KH; Park GY; Lee TY; Suh SI
Toxicol In Vitro; 2009 Mar; 23(2):281-7. PubMed ID: 19135517
[TBL] [Abstract][Full Text] [Related]
13. N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model.
Baker DP; Lin EY; Lin K; Pellegrini M; Petter RC; Chen LL; Arduini RM; Brickelmaier M; Wen D; Hess DM; Chen L; Grant D; Whitty A; Gill A; Lindner DJ; Pepinsky RB
Bioconjug Chem; 2006; 17(1):179-88. PubMed ID: 16417267
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of five xenografted human cancers and two murine cancers by the tripeptide tyroservatide.
Fu Z; Lu R; Jia J; Zhao L; Ma R; Lv JQ; Li XL; Chen LJ; Zhang HL; Wang L; Yao Z
Anticancer Drugs; 2007 Apr; 18(4):467-70. PubMed ID: 17351399
[TBL] [Abstract][Full Text] [Related]
15. Antitumor efficiency of novel fluoro-substituted 6-amino-2-phenylbenzothiazole hydrochloride salts in vitro and in vivo.
Stojkovic R; Karminski-Zamola G; Racane L; Tralic-Kulenovic V; Glavas-Obrovac L; Ivankovic S; Radacic M
Methods Find Exp Clin Pharmacol; 2006; 28(6):347-54. PubMed ID: 16894403
[TBL] [Abstract][Full Text] [Related]
16. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
17. Combination of vasostatin gene therapy with cyclophosphamide inhibits growth of B16(F10) melanoma tumours.
Jazowiecka-Rakus J; Jarosz M; Szala S
Acta Biochim Pol; 2006; 53(1):199-202. PubMed ID: 16388313
[TBL] [Abstract][Full Text] [Related]
18. Liposomal N,N,N-trimethylsphingosine (TMS) as an inhibitor of B16 melanoma cell growth and metastasis with reduced toxicity and enhanced drug efficacy compared to free TMS: cell membrane signaling as a target in cancer therapy III.
Park YS; Hakomori S; Kawa S; Ruan F; Igarashi Y
Cancer Res; 1994 Apr; 54(8):2213-7. PubMed ID: 8174128
[TBL] [Abstract][Full Text] [Related]
19. Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways.
Park H; Bergeron E; Senta H; Guillemette K; Beauvais S; Blouin R; Sirois J; Faucheux N
Biochem Biophys Res Commun; 2010 Aug; 399(3):446-51. PubMed ID: 20678472
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of 2-[4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridine-4-yl)-1H-pyrazol-1-yl]ethan-1-ol (GDC-0879), a potent and selective B-Raf kinase inhibitor: understanding relationships between systemic concentrations, phosphorylated mitogen-activated protein kinase kinase 1 inhibition, and efficacy.
Wong H; Belvin M; Herter S; Hoeflich KP; Murray LJ; Wong L; Choo EF
J Pharmacol Exp Ther; 2009 Apr; 329(1):360-7. PubMed ID: 19147858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
